Stay updated on Camidanlumab Tesirine in Hodgkin Lymphoma Clinical Trial

Sign up to get notified when there's something new on the Camidanlumab Tesirine in Hodgkin Lymphoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Camidanlumab Tesirine in Hodgkin Lymphoma Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    Page revision updated to v3.4.2 (replacing v3.4.1); this minor behind-the-scenes change does not affect study content. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-02-14T03:44:11.000Z thumbnail image
  2. Check
    12 days ago
    Change Detected
    Summary
    Revision: v3.4.1 is now displayed, replacing Revision: v3.4.0. This appears to be a minor backend/version update with no changes to study content or user-facing information.
    Difference
    0.0%
    Check dated 2026-02-07T04:43:26.000Z thumbnail image
  3. Check
    19 days ago
    No Change Detected
  4. Check
    26 days ago
    Change Detected
    Summary
    Glossary is now shown; QC-related labels and the page footer revision have been updated.
    Difference
    0.1%
    Check dated 2026-01-23T21:41:48.000Z thumbnail image
  5. Check
    33 days ago
    Change Detected
    Summary
    Only a minor site version update occurred (Revision: v3.3.4 added; Revision: v3.3.3 removed), with no changes to the page content or study data. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-01-17T00:31:35.000Z thumbnail image
  6. Check
    54 days ago
    Change Detected
    Summary
    Added a Blood Advances 2025 Dec 9 publication citation for Camidanlumab tesirine phase 2 study and removed the earlier Blood Advances online-ahead-of-print citation.
    Difference
    0.0%
    Check dated 2025-12-26T14:16:21.000Z thumbnail image
  7. Check
    62 days ago
    Change Detected
    Summary
    Locations were expanded to include a comprehensive list of study sites (Arizona, California, Florida, Georgia, Illinois, Kentucky, Minnesota, Missouri, New Jersey, New York, Ohio, South Carolina, Texas, Virginia, Wisconsin, and British Columbia) and the study revision was updated from v3.3.2 to v3.3.3.
    Difference
    1%
    Check dated 2025-12-19T10:29:15.000Z thumbnail image

Stay in the know with updates to Camidanlumab Tesirine in Hodgkin Lymphoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Camidanlumab Tesirine in Hodgkin Lymphoma Clinical Trial page.